Form 4: Director Chan Nelson C Acquires Twist Bioscience Corp Shares
SEC Form 4 Filing
Director Chan Nelson C acquired 4,472 shares of Twist Bioscience Corp common stock on February 5, 2025, and disposed of 28,156 shares.
Summary
- On February 5, 2025, Director Chan Nelson C acquired 4,472 shares of Twist Bioscience Corp common stock.
- The acquisition was made at a price of $0 per share.
- Following the transaction, the director directly owns 28,156 shares.
- The director also disposed of 28,156 shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing, reflecting neutral sentiment as it reports transaction details without expressing any opinion or outlook.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of company executives and directors.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 02/05/2025 | Date of transaction: acquisition and disposal of shares. |
| 02/07/2025 | Date of signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.